Edny InuiDirector of Business Development at Caribou Biosciences
Dr. Edny Inui is the Director of Business Development at Caribou Biosciences. Caribou is a leading company in CRISPR genome editing founded by pioneers of CRISPR-Cas9 biology. Caribou’s proprietary technologies put the company at the forefront of the development of new medical therapies. The company is developing an internal pipeline of off-the-shelf CAR-T cell therapies, other gene-edited cell therapies, and engineered gut microbes. Prior to joining Caribou, Dr. Inui was a Senior Manager of Business Development and Strategy at Acadia Pharmaceuticals, San Diego, CA. From 2010 to 2016, Dr. Inui was a Senior Biotechnology Analyst for Biomedtracker, a leading life science investment research firm. Dr. Inui earned a B.S. in Biology from the Massachusetts Institute of Technology, a Ph.D. in Neuroscience from the University of Michigan, and an MBA from the University of Chicago Booth School of Business. She conducted post-doctoral training in Aging at the University of California San Diego.